Cardinal Health, Inc. $CAH Stock: Kintegral Advisory LLC Raises Stake

Key Points

• Kintegral Advisory LLC increased its Cardinal Health stake by 349.4% in the third quarter, holding 21,634 shares valued at approximately $4.8 million. Institutional investors collectively own 87.17% of the company.
• Cardinal Health shares recently traded near their 12-month high at $253.86, while analysts maintain a “Moderate Buy” consensus with an average price target of $267.50.
• The company exceeded quarterly earnings expectations with $2.91 in EPS versus a $2.42 estimate, and recently paid a quarterly dividend of $0.5158 per share, yielding about 0.8% annually.

Kintegral Advisory LLC lifted its position in shares of Cardinal Health, Inc. (NYSE:CAH - Free Report) by 349.4% during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 21,634 shares of the company's stock after acquiring an additional 16,820 shares during the period. Kintegral Advisory LLC's holdings in Cardinal Health were worth $4,814,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also made changes to their positions in the company. Bank of New York Mellon Corp bought a new stake in shares of Cardinal Health during the 2nd quarter worth about $308,640,000. First Nebraska Trust Co bought a new position in shares of Cardinal Health in the second quarter valued at approximately $20,050,000. Castlekeep Investment Advisors LLC bought a new position in shares of Cardinal Health in the second quarter valued at approximately $1,177,000. Stack Financial Management Inc acquired a new position in shares of Cardinal Health during the second quarter valued at approximately $24,681,000. Finally, NewEdge Advisors LLC increased its stake in shares of Cardinal Health by 52.9% during the first quarter. NewEdge Advisors LLC now owns 33,939 shares of the company's stock valued at $7,172,000 after acquiring an additional 11,740 shares during the period. 87.17% of the stock is owned by institutional investors and hedge funds.

Cardinal Health Stock Performance

NYSE CAH traded up $0.15 on Friday, reaching $253.86. The company's stock had a trading volume of 1,336,496 shares, compared to its average volume of 1,856,656. Cardinal Health, Inc. has a twelve month low of $152.46 and a twelve month high of $258.30. The stock has a market cap of $58.78 billion, a PE ratio of 35.11, a PEG ratio of 1.53 and a beta of 0.50. The firm's 50 day moving average is $234.54 and its two-hundred day moving average is $222.22.

Cardinal Health (NYSE:CAH - Get Free Report) last posted its quarterly earnings data on Tuesday, August 11th. The company reported $2.91 earnings per share for the quarter, beating the consensus estimate of $2.42 by $0.49. The company had revenue of $63.67 billion during the quarter, compared to analyst estimates of $65.15 billion. Cardinal Health had a net margin of 0.67% and a negative return on equity of 98.53%. The business's revenue for the quarter was up 5.8% on a year-over-year basis. During the same quarter last year, the firm posted $2.08 EPS. Cardinal Health has set its FY 2027 guidance at 12.400-12.600 EPS. Equities research analysts anticipate that Cardinal Health, Inc. will post 12.55 EPS for the current fiscal year.

Cardinal Health Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Thursday, October 15th. Investors of record on Thursday, October 1st were issued a dividend of $0.5158 per share. This represents a $2.06 dividend on an annualized basis and a yield of 0.8%. The ex-dividend date was Thursday, October 1st. Cardinal Health's dividend payout ratio (DPR) is presently 28.49%.

Wall Street Analyst Weigh In

Several brokerages recently commented on CAH. Royal Bank Of Canada started coverage on Cardinal Health in a report on Wednesday, August 19th. They set an "outperform" rating and a $276.00 target price on the stock. Morgan Stanley increased their price target on Cardinal Health from $255.00 to $265.00 and gave the company an "overweight" rating in a research note on Wednesday, August 12th. Wells Fargo & Company increased their price target on Cardinal Health from $245.00 to $277.00 and gave the company an "overweight" rating in a research note on Wednesday, August 12th. TD Cowen lifted their price target on Cardinal Health from $275.00 to $280.00 and gave the company a "buy" rating in a research report on Thursday, August 13th. Finally, Citigroup boosted their price objective on Cardinal Health from $265.00 to $280.00 and gave the stock a "buy" rating in a research note on Wednesday, August 12th. Sixteen research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. According to data from MarketBeat, the company has a consensus rating of "Moderate Buy" and a consensus price target of $267.50.

Insider Activity

In other Cardinal Health news, CAO Mary C. Scherer sold 2,302 shares of the company's stock in a transaction on Wednesday, August 19th. The stock was sold at an average price of $237.39, for a total value of $546,471.78. Following the transaction, the chief accounting officer owned 2,811 shares of the company's stock, valued at approximately $667,303.29. This represents a 45.02% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CEO Deborah Weitzman sold 7,354 shares of the stock in a transaction on Tuesday, August 18th. The shares were sold at an average price of $235.45, for a total value of $1,731,499.30. Following the sale, the chief executive officer owned 77,901 shares of the company's stock, valued at $18,341,790.45. This trade represents a 8.63% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders sold a total of 210,271 shares of company stock valued at $49,626,657 in the last ninety days. 0.12% of the stock is owned by company insiders.

Cardinal Health Company Profile

Cardinal Health, Inc is a healthcare services and products company that supports pharmacies, hospitals, ambulatory surgery centers, physician offices and other healthcare providers. Its operations are primarily organized into Pharmaceutical and Medical segments.

The Pharmaceutical segment distributes branded, generic, specialty and over-the-counter medicines, as well as consumer health products. It also provides services related to specialty pharmaceuticals, pharmaceutical sourcing, nuclear and precision health products, and data and analytics for pharmaceutical manufacturers and healthcare organizations.

The Medical segment distributes medical and surgical products, including gloves, apparel, incontinence supplies, laboratory products and other essential items.

Want to see what other hedge funds are holding CAH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cardinal Health, Inc. (NYSE:CAH - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.